Pharma Journalist - Page 38 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

China Accepts BLA for Subcutaneous LEQEMBI Formulation

Insilico Medicine, Servier Partner on AI-Driven Oncology Drug Discovery

FDA Grants Priority Review for Tzield Pediatric Indication Expansion

Takeda, Protagonist File NDA for Rusfertide in Polycythemia Vera

Canada Approves Arrowhead’s REDEMPLO for Rare Triglyceride Disorder

Harbour BioMed, Bristol Myers Squibb Partner on Multi-Specific Antibodies

FDA Approves GSK’s Twice-Yearly Biologic for Severe Eosinophilic Asthma

Alnylam Expands Massachusetts Facility to Advance RNAi Manufacturing

Phase 3 Trial Shows Survival Gains in Muscle-Invasive Bladder Cancer

Takeda Reports Strong Phase 3 Results for Oral Psoriasis Therapy